VeriMomeucalyptus globulus leaf extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
Pregnancy-safe products containing eucalyptus globulus leaf extract
Related ingredients
Frequently asked questions
- eucalyptus globulus leaf extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
- eucalyptus globulus leaf extract emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Systemic absorption of volatile constituents is possible after topical application, so low but measurable exposure to lactating parent is plausible; no data indicate transfer to breastmilk or harmful effects in breastfed infants (sources: PubChem, PubMed, absence of ECHA harmonised classification).
- eucalyptus globulus leaf extract bebek cildi için güvenli mi?
- No specific data showing developmental or reproductive toxicity in infants from topical cosmetic use of the leaf extract and no harmonised CLP reproductive hazard. However, infant skin has higher permeability and eucalyptus materials (notably eucalyptus oil/1,8‑cineole) are reported in the literature to cause adverse effects in young children when ingested or used inappropriately; therefore dermal exposure is judged as moderate (adult exposure scored as low measurable, increased by +1 for infants). No infant‑specific mechanistic evidence of reproductive endocrine disruption was found (sources: PubMed reports of pediatric toxicity from eucalyptus oil ingestion, EWG entries; no ECHA Annex VI reproductive flags).
- VeriMom eucalyptus globulus leaf extract nasıl puanlıyor?
- VeriMom eucalyptus globulus leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte eucalyptus globulus leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.